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m
entaries
End-of-Life Care and Opioid Use in India:
Challenges and Opportunities
In2011, theWHOestimated that20millionpeople
required end-of-life palliative care, of whom 78%
lived in low- and middle-income countries.1 In a
country like India, which contains 17.5% of the
world population, end-of-life palliative care is al-
most nonexistent, aswasnoted in the2015Quality
of Death Index by The Economist Intelligence
Unit.2,3According to estimates from India, approx-
imately 10 million people may require palliative
care services, of whom 1 million have cancer and
7 million have other life-limiting conditions.4 It
is estimated that the yearly incidence of cancer
in India will increase from 1 million in 2015 to
1.7 million by 2035.5 The 2015 Global Burden of
Disease data estimated that 675,000 persons die
with a diagnosis of cancer every year in India.6 The
gravity of the situation could not be any more
evident than in the fact that more than 26,000
individuals suffering from cancer, AIDS, paralysis,
and other chronic illnesses ended their life in 2013,
accounting for nearly 20% of all deaths caused by
self-harm in India.7
Ease of access to opioid pain medications is an
integral component of effective palliative care ser-
vice. In India, poppy plants are grown only in three
statesandare under strict government licensing.8
The government-owned company Opium and Al-
kaloid Works has only two factories processing raw
materials from poppy plants into morphine sulfate
powder for the entire country.9 Manufacturers ob-
tain the compound from the factory, which is then
converted into tablets and injections. Total mor-
phine consumption in India was a paltry 278 kg
in 2014.10 If a patient with terminal cancer requires
75 mg of morphine per day for pain relief for
approximately 90 days, this amount of 278 kg is
only sufficient to adequately treat 40,000patients.11
In the initial phases of palliative care in India,
morphine and pethidine were the only opioid pain
medications available, and pethidine is not rec-
ommended for chronic pain.12 Awareness about
opioid medications increased during the early
1980s, and morphine use increased during the
time. This raised concerns regarding diversion of
the medication and prompted the government to
institute the Narcotic Drugs and Psychotropic Sub-
stances (NDPS) Act in 1985.
Althoughcancerpain reliefwas identified asoneof
the basic services provided at the primary health
centers in the country in the National Cancer
Control Program in 1984, the practicality of this
goalwasnegatedwith thenewNDPSAct. Asmany
as six licenses were required for every consign-
ment of morphine, and physicians possessing
opiates after expiry of license could face arrest
without bail and a jail term of up to 20 years. The
use of morphine decreased from 716 kg in 1985
to a mere 18 kg by 1997 (data obtained through
Pain and Policy Studies Group: University of
Wisconsin/WHOCollaboratingCenter fromannual
consumption report submitted by countries to In-
ternational Narcotics Control Board). This drastic
decrease raised concerns, and the International
Narcotics Control Board forewarned the govern-
ment and advised to ensure the availability of
opioids for medical purposes.13,14
For the palliative care community, management
of accounts regarding storage of morphine and
its dispensing was also cumbersome as a result
of the frequent regulatory procedures. Even when
demand started to increase by the early 2000s,
supply was a limiting factor. As a result of the
difficulty in obtaining a license for the manufacture
of morphine and the need for frequent renewal,
there was a significant shortage of opiate medica-
tions. Soon, physicians moved to alternate analge-
sic options.15 Even in places where morphine was
available, patients were only given short supplies of
medications. The ban on dextropropoxyphene in
India further complicated the situation for patients
and health care providers.16 However, strong and
persistent advocacy from palliative care providers
and patient support groups led to the amendment
of the NDPS Act in 2014 (Table 1). Opioid medi-
cation licensing was unified and brought under the
purview of the federal government. Under the cur-
rent law, to procure and dispensemorphine, only a
single license is now necessary. As a result, it has
become significantly easier to obtain morphine for
use in palliative care.
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Despite the amendment in laws, reports suggest that
palliativecareservices in Indiaremaindismal.3Focus
has since shifted to understanding the barriers for
effective implementation of the law. A significant
hurdle in improving the access to pain medications
lies at the feet of the medical community in India.
Physicians andmedical professionals lack appropri-
ate knowledge regarding opioid pain medications.
For instance, a study found that nearly 90% of 326
medical students thought that morphine use in pal-
liative care would result in drug addiction.17 It is
important for medical students to understand that
termssuchasphysiologicdependenceandtolerance
are obsolete in the case of end-stage palliative
care treatment. Integration of palliative care as an
academic discipline into the undergraduate medical
curriculum and establishment of more postgraduate
educational programs in palliative care would greatly
improve provision of appropriate pain relief to thou-
sands of patients suffering fromcancer andother life-
limiting illnesses. Another barrier to effective imple-
mentation is centered on a purported concern for
opioidmisuse or diversion.We suggest that this issue
is not valid in India, where no apparent discrepancies
occur during stages of morphine production and
distribution.15 Sociocultural influences make people
consider pain medications as toxic, sometimes even
to the extent of hiding their symptoms from physi-
cians. Improvedawarenessof thebenefits of palliative
care services can effectively address these sociocul-
turalbarriers toseekingpainreliefnear theendof life.
In 2008, the southern Indian state of Kerala emu-
lated a palliative care policy, prompting other states
to enact similar policies. The policy was aimed at
training more providers and volunteers and estab-
lishing more palliative care programs, especially
in the primary care setting.18 The contribution of
community-based organizations resulted in a great
advance in palliative care delivery; Kerala state now
hasmore palliative care centers than the rest of the
country put together, despite having just 3% of the
country’s population. The World Palliative Care
Alliance and WHO advocated this as a highly sus-
tainable palliative care model.1 The program had
approximately 50,000 beneficiaries in 2014 and
obtained budgetary support from local and state
governments. However, the situation has improved
onlymarginally in the rest of the country, with only a
nominal increase in the number of palliative care
centers.19
Balancing these virtues and vices ina cost-effective
setting within this multicultural society is a gargan-
tuan task that the Indian government and palliative
care community has currently undertaken. Any
positive or negative outcomes from the different
models launched in various sociopolitical, geo-
graphic, and cultural conditions of the country
would help formulate a palliative care model for
low- and middle-income countries with minimal
palliative care activities.1 The palliative care com-
munity is optimistic about the new NDPS amend-
ment, whichmay helpmake pain relief accessible
to millions. However, it is faced with the task of
restructuringmedical education to equip the hun-
dreds of thousands of doctors and ancillary med-
ical personnel who have never seen or ordered
opioid pain medications in their lives.
DOI: https://doi.org/10.1200/JGO.2016.008490
Published online on jgo.org on January 25, 2017.
Table 1. Major Legislation Regarding Use of Opiates in India
Year Major Legislation Regarding Use of Opiates in India
1857 OpiumAct:Nationalizingcultivationof poppyandmanufactureof opium in
British Colonial India.
1878 OpiumAct amendment: Aimed to decrease opiumuse in India primarily to
promote export. Sale authorized only to registered Chinese opium
smokers and Indian opium eaters. Ban of opium in Burma.
1906 England andChina sign treaty to restrict Sino-Indian opium trade as opiate
addiction reaches alarming levels.
1930 TheDangerousDrugsAct:Unifying theopiumrules across IndianUnionas
per adoption of Geneva Convention.
1985 The Narcotic Drugs and Psychotropic Substances Act supersedes all
previous acts. Strict rules enforced for production, manufacture,
storage, prescription, and use of morphine and other psychotropic
substances.
2014 Amendment to Narcotic Drugs and Psychotropic Substances Act:
Important provisions and changes include the following:
a. Uniform narcotic regulations in all states and union territories across
the country
b. To ensure uniformity, the power for any further amendment of the rules
regarding essential narcotic drugs is vestedwith the central government
only
c. An institution will require only a single license approving them as
a recognized medical institution instead of the previous requirement
of 4-5 licenses
d.Thedrugscontroller ofeachstatewill be responsible for licensing instead
of multiple departmental licenses, which were required earlier
e. Ensure availability of pain medications in hospitals and its accessibility
to patients with severe pain
f. Instituting evidence-based and human right–compliant standards for
facilities treating drug dependence
g. Opening up private sector in processing of opium and concentrated
poppy straw
h.Punishment for holdingopiateswithout licensewill be6months to1 year
imprisonment for a small quantity and 20 years for a commercial
quantity; an alternative 30-year imprisonment instead of themandatory
death sentence for subsequent offenses involving significant quantity
of drugs
NOTE. Information was obtained from the Central Bureau of Narcotics at www.cbn.nic.in.
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